TMB levels were positively correlated with microsatellite instability (MSI) and PD-L1 expression (Figures 10F, G), suggesting that increased mutational load may contribute to enhanced immunogenicity and immune checkpoint activation in prostate cancer. The gene discussed is CD274; the disease is prostate carcinoma.